Abstract: A process can be used for preparing nano- or microparticles containing a carrier-polymer and a biologically active ingredient. The process is a solvent emulsion process involving an organic phase (OP) and an aqueous phase (AP) to form an emulsion. In the case of an oil-in-water emulsion (O/W), the organic phase (OP) contains the biologically active ingredient dissolved or dispersed therein. Alternatively, in the case of a water-in-oil emulsion (W1/O), the aqueous phase (AP) contains the biologically active ingredient dissolved or dispersed therein. The organic phase (OP) is saturated with the salt-containing aqueous phase (AP) and vice versa.

Abstract: The present invention relates to a process for the production of a homogenous mixture of two or more branched chain keto acids wherein in a first step, two or more free keto acids are mixed, and in a second step, the mixed keto acids are co-crystallized with one or more alkaline earth metal salts, and foodstuff, food supplement or pharmaceutical products containing a mixture of branched-chain keto acids for supporting muscle structure, increasing muscle performance and improving general wellbeing with simultaneous relief of nitrogen detoxification metabolism by reduced nitrogen supply compared to the intake of the corresponding amino acids and an improved nitrogen metabolism in the body.

Abstract: The present invention is directed to bioresorbable polymers to be used as bone and tissue adhesives. The present invention is also directed to the synthesis of bioresorbable polymeric molecules bearing adhesive moieties and the use of such compounds in methods to glue and stabilize fractured bones and damaged tissues. The present invention is also directed to the use of such compounds as adhesive sealants for applications in wound care. The present invention is also directed to the use of such compounds as biodegradable ink for applications in tissue engineering and 3D printing. The present invention also relates to the use of such compounds as drug delivery platforms.

Abstract: The present invention relates to a method for the determination of processing influences on the quality of feedstuff raw materials and/or feedstuffs, in which the processing conditions indicator of the of feedstuff raw materials and/or feedstuffs is determined and the specific digestibility coefficient of an amino acid of a feedstuff raw material and/or feedstuff in an animal species is determined. The present invention also relates to a process for the optimization of feedstuffs considering the determined processing influences and the thus obtained and/or obtainable feedstuffs.

Abstract: The present invention relates to a method for detecting C. perfringens induced diseases in animals, the method comprising: a) collecting sample material of a specific animal or of a specific group of animals at consecutive points in time; b) determining the amount of a first marker and a second marker contained in the sample material; and c) determining the ratio of the first marker to the second marker contained in the sample material; wherein the first marker comprises a polynucleotide sequence being specific for the C. perfringens sub-species inducing the targeted disease; and the second marker comprises a polynucleotide being specific for the species C. perfringens; and wherein an increase in the ratio of the first marker to the second marker in the analyzed sample material over time is an indication of the targeted disease.

Abstract: The invention relates to a process for preparing a carboxylic ester by reacting an aldehyde in the presence of an aluminum alkoxide, wherein the aluminum alkoxide is obtained either by reacting an aluminum hydride with an aldehyde or by reacting a different aluminum alkoxide with a carboxylic ester.

Abstract: An additive composition contains a viscosity index improver and a pour point depressant. A process can be used for preparing the additive composition. The additive composition can be used as a lubricant additive in a lubricating oil formulation, and lubricating oil formulations can contain the additive composition.

Abstract: A preparation comprising probiotic strains belonging to the genera Bacillus sp., Lactobacillus sp., optionally Pediococcus sp. as viable cells or cytoplasmic extract thereof, and proteases, wherein the strains can degrade peptide sequences of gliadins. The preparation can be used to produce gluten-free foods from gluten-containing cereals or to treat gluten-related disorders.

Abstract: Polymer foams based on polyetherimides (PEI) or blends of polyetherimides and polyether ether ketone (PEEK) meet the legal requirements demanded by the aviation industry for aircraft interiors and for aircraft exteriors too.

Abstract: The present invention relates generally to amine curing agents compositions useful in formulation additives, compositions comprising systems, resin formulations, and the use of these compositions in methods of making objects by additive manufacturing using 3D printing methodologies.

Abstract: A process for making propene oxide involves reacting propene with hydrogen peroxide in the presence of methanol, a titanium zeolite epoxidation catalyst, and nitrogen containing compounds present in an amount of from 100 to 3000 mg/kg of hydrogen peroxide. Non-reacted propene is separated from the reaction mixture; the propene depleted reaction mixture Is continuously distilled in a distillation column providing an overhead product stream containing propene oxide and methanol and a bottoms product stream; and propene oxide is separated from the overhead product stream. An acid is added to the propane depleted reaction mixture and/or to the distillation column at the same level or above the feed point for the propene depleted reaction mixture and/or contacted to the feed to the distillation column to provide an apparent pH in the bottoms product stream of from 3 to 4.5, which reduces the nitrogen content of the separated propene oxide.

Abstract: A process can be used for recovering 1-methoxy-2-propanol and 2-methoxy-1-propanol from an aqueous effluent stream by liquid-liquid-extraction, followed by extractive distillation, distillation of methoxypropanols from the extraction solvent, and distillative separation of the methoxypropanol isomers. Recovered extraction solvent is recycled to the extraction and extractive distillation. Heat transfer from recovered extraction solvent to the extract fed to the extractive distillation reduces energy demand of the process. A facility for this process contains a countercurrent extraction column, an extractive distillation column, a solvent recovery distillation column, an isomer separation distillation column, and a heat exchanger for transferring heat from recovered extraction solvent to the extract fed to the extractive distillation.

Abstract: Methods can be used for producing three-dimensional objects by powder bed fusion, using inks containing superparamagnetic particles and solvents. Sintering is performed by a magnetic field having a frequency of 50 kHz to 5 GHz.

Abstract: A composition contains glycolipids and Methyl citrate (TEC). The TEC can assist in stabilizing a foam of a corresponding aqueous composition. A method can be used for preparing a corresponding formulation, preferably a cosmetical or pharmaceutical formulation, by providing the composition and diluting the composition.

Abstract: An extractive distillation column system contains a combination column and a side rectification column. A process can be used for separation of butenes from C4-hydrocarbon streams using the extractive distillation column system.

Abstract: Process for the alkoxycarbonylation of trivinylcyclohexane.

Abstract: Disclosed herein are methods, systems, and compositions for providing catalysts for tail gas clean up in sulfur recovery operations. Aspects of the disclosure involve obtaining catalyst that was used in a first process, which is not a tailgas treating process and then using the so-obtained catalyst in a tailgas treating process. For example, the catalyst may originally be a hydroprocessing catalyst. A beneficial aspect of the disclosed methods and systems is that the re-use of spent hydroprocessing catalyst reduces hazardous waste generation by operators from spent catalyst disposal. Ultimately, this helps reduce the environmental impact of the catalyst life cycle. The disclosed methods and systems also provide an economically attractive source of high-performance catalyst for tailgas treatment, which benefits the spent catalyst generator, the catalyst provider, and the catalyst consumer.

Abstract: The present invention relates to a process for producing silica-based thermal insulation moulded body comprising at least 50% by weight of synthetic amorphous silica and not more than 50% by weight of natural silica with a specified particle size, thermal insulation moulded body obtainable by this process and the use thereof for thermal and/or acoustic insulation.

Abstract: The invention relates to triesters of cyclohexanetripropionic acid, preparation thereof and use thereof as plasticizers for polymers wherein examples of the triester of cyclohexanetripropionic acid include tri(nbutyl) cyclohexane-1,2,4-tripropionate, tri(methylpropyl) cyclohexane-1,2,4-tripropionate, tri(npentyl) cyclohexane-1,2,4-tripropionate, tri(isopentyl) cyclohexane-1,2,4-tripropionate, tri(2-methylbutyl) cyclohexane-1,2,4-tripropionate, tri(3-methylbutyl) cyclohexane-1,2,4-tripropionate, tri(nhexyl) cyclohexane-1,2,4-tripropionate, tri(isohexyl) cyclohexane-1,2,4-tripropionate, tri(nheptyl) cyclohexane-1,2,4-tripropionate, tri(isoheptyl) cyclohexane-1,2,4-tripropionate, tri(noctyl) cyclohexane-1,2,4-tripropionate, tri(isooctyl) cyclohexane-1,2,4-tripropionate, tri(2-ethylhexyl) cyclohexane-1,2,4-tripropionate, tri(nnonyl) cyclohexane-1,2,4-tripropionate, tri(isononyl) cyclohexane-1,2,4-tripropionate, tri(ndecyl) cyclohexane-1,2,4-tripropionate, tri(isodecyl) cyclohexane-1,2,4-tripropionate, and tri(2-p

Abstract: The present invention relates to a tablet comprising one or more omega-3 fatty acid amino acid salts, a method for preparing a tablet according to the invention and the use of a tablet according to the invention as a food supplement or as a pharmaceutical product.